Dr John Dearing Bryan, MD in Tulsa, OK - Ophthalmology

Dr John Dearing Bryan, MD is a Ophthalmology physician based in Tulsa, Oklahoma. Dr John Dearing Bryan is licensed to practice in Oklahoma (license number 11755) and his current practice location is 7171 S Yale Ave, Suite 102, Tulsa, Oklahoma. He can be reached at his office (for appointments etc.) via phone at (918) 481-6630.

NPI number for Dr John Dearing Bryan is 1770574709 and his current mailing address is 7171 S Yale Ave, Suite 102, Tulsa, Oklahoma. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1770574709.

Contact Information

	Dr John Dearing Bryan, MD
	7171 S Yale Ave, Suite 102, Tulsa, OK 74136-6367
	(918) 481-6630
	(918) 481-6698

Physician's Profile

Full Name	Dr John Dearing Bryan
Gender	Male
Speciality	Ophthalmology
Location	7171 S Yale Ave, Tulsa, Oklahoma
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1770574709
Provider Enumeration Date: 10/31/2005
Last Update Date: 06/17/2010

Medical Identifiers

Medical identifiers for Dr John Dearing Bryan such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1770574709	NPI	-	NPPES
100079040A	Medicaid	OK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	11755 (Oklahoma)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Dearing Bryan is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John Dearing Bryan, MD 7171 S Yale Ave, Suite 102, Tulsa, OK 74136-6367 Ph: (918) 481-6630	Dr John Dearing Bryan, MD 7171 S Yale Ave, Suite 102, Tulsa, OK 74136-6367 Ph: (918) 481-6630

News Archive

Trigeminal Nerve Stimulation: an interview with Dr Leon Ekchian, President and CEO of NeuroSigma

Trigeminal Nerve Stimulation (TNS) is a novel medical treatment in which mild electrical signals stimulate branches of the trigeminal nerve in order to change the activity of targeted brain regions. The trigeminal nerve is the largest cranial nerve, and provides sensation to the face and head. Because it is a large sensory nerve, the trigeminal offers a high-bandwidth pathway for electrical signals to enter the brain. The brain areas targeted by TNS are known to play key roles in seizures, mood, and attention.

Amorcyte receives patent for chemotactic hematopoietic stem cell product

Amorcyte, Inc., a biopharmaceutical company developing cell therapy products to treat cardiovascular disease, today announced that it has been granted United States Patent number 7,794,705 titled "Compositions and Methods of Vascular Injury Repair." The patent contains both composition of matter and method claims surrounding therapeutic chemotactic hematopoietic stem cell products used in treating or repairing a vascular injury following an acute myocardial infarction (AMI), and delivery of the cell therapy.

Cleveland Clinic to study ecological, evolutionary mechanisms that contribute to lung cancer

Jacob Scott, M.D., Ph.D., a physician researcher from Cleveland Clinic's Department of Translational Hematology and Oncology Research, recently received a $2.8 million grant from the National Cancer Institute, part of the National Institutes of Health, to study how ecological and evolutionary mechanisms contribute to lung cancer development and progression, and how the interplay between these mechanisms may provide novel treatment insights.

Study aims to elucidate the prevalence and etiology of PoPH in patients with chronic liver disease

Portopulmonary hypertension (PoPH) is a form of pulmonary arterial hypertension (PAH). PoPH occurs in approximately 15% of patients with PAH, and is reportedly found in 2-6% of patients with portal hypertension and 1-2% of patients with liver cirrhosis according to studies from Europe and America.

Hospitals face cuts, restructuring to cope with flagging economy

"The nation's largest public hospital system plans to slash its work force—including doctors and nurses—by about 10% over two years as government aid drops and the number of uninsured patients jumps," The Wall Street Journal reports.

Ophthalmology Doctors in Tulsa, OK

Mark Justin Weiss, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1717 S Utica Ave, Ste 107, Tulsa, OK 74104 Phone: 918-742-2428 Fax: 918-742-8435
Anthony Economou, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2865 E Skelly Dr Ste 250, Tulsa, OK 74105 Phone: 918-317-0022 Fax: 855-327-9828
Dr. Justin Parschauer, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6600 S Yale Ave, Suite 800, Tulsa, OK 74136 Phone: 918-491-3900
Dr. Zeb Linston Brister, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 3906 S Peoria Ave, Tulsa, OK 74105 Phone: 918-585-1523 Fax: 918-584-5520
John Thomas Romano, D.O. Ophthalmology Medicare: Medicare Enrolled Practice Location: 4444 S Harvard Ave, Ste 300, Tulsa, OK 74135 Phone: 918-747-2020 Fax: 918-747-2056
Dr. Bruce Ben Pettigrove, M.D. Ophthalmology Medicare: May Accept Medicare Assignments Practice Location: 6606 S. Yale, #220, Tulsa, OK 74136 Phone: 918-492-4122 Fax: 918-492-7451
Shehzad Y Batliwala, D.O Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10010 E 81st St Ste 100, Tulsa, OK 74133 Phone: 918-250-2020

Dr John Dearing Bryan, MD - Ophthalmology in Tulsa, OK